BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 32287312)

  • 21. Identifying Plasma Derived Extracellular Vesicle (EV) Contained Biomarkers in the Development of Chronic Neuropathic Pain.
    Sosanya NM; Kumar R; Clifford JL; Chavez R; Dimitrov G; Srinivasan S; Gautam A; Trevino AV; Williams M; Hammamieh R; Cheppudira BP; Christy RJ; Crimmins SL
    J Pain; 2020; 21(1-2):82-96. PubMed ID: 31228575
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA‑34a‑5p expression in the plasma and in its extracellular vesicle fractions in subjects with Parkinson's disease: An exploratory study.
    Grossi I; Radeghieri A; Paolini L; Porrini V; Pilotto A; Padovani A; Marengoni A; Barbon A; Bellucci A; Pizzi M; Salvi A; De Petro G
    Int J Mol Med; 2021 Feb; 47(2):533-546. PubMed ID: 33416118
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differentially expressed miRNAs in retinoblastoma.
    Martin J; Bryar P; Mets M; Weinstein J; Jones A; Martin A; Vanin EF; Scholtens D; Costa FF; Soares MB; Laurie NA
    Gene; 2013 Jan; 512(2):294-9. PubMed ID: 23103829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA-129-5p suppresses proliferation, migration and invasion of retinoblastoma cells through PI3K/AKT signaling pathway by targeting PAX6.
    Liu Y; Liang G; Wang H; Liu Z
    Pathol Res Pract; 2019 Dec; 215(12):152641. PubMed ID: 31727502
    [TBL] [Abstract][Full Text] [Related]  

  • 25. EV-associated miRNAs from peritoneal lavage as potential diagnostic biomarkers in colorectal cancer.
    Roman-Canal B; Tarragona J; Moiola CP; Gatius S; Bonnin S; Ruiz-Miró M; Sierra JE; Rufas M; González E; Porcel JM; Gil-Moreno A; Falcón-Pérez JM; Ponomarenko J; Matias-Guiu X; Colas E
    J Transl Med; 2019 Jun; 17(1):208. PubMed ID: 31221189
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased number of circulating exosomes and their microRNA cargos are potential novel biomarkers in alcoholic hepatitis.
    Momen-Heravi F; Saha B; Kodys K; Catalano D; Satishchandran A; Szabo G
    J Transl Med; 2015 Aug; 13():261. PubMed ID: 26264599
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor microRNA expression profiling identifies circulating microRNAs for early breast cancer detection.
    Matamala N; Vargas MT; González-Cámpora R; Miñambres R; Arias JI; Menéndez P; Andrés-León E; Gómez-López G; Yanowsky K; Calvete-Candenas J; Inglada-Pérez L; Martínez-Delgado B; Benítez J
    Clin Chem; 2015 Aug; 61(8):1098-106. PubMed ID: 26056355
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vesicle-bound EBV-BART13-3p miRNA in circulation distinguishes nasopharyngeal from other head and neck cancer and asymptomatic EBV-infections.
    Ramayanti O; Verkuijlen SAWM; Novianti P; Scheepbouwer C; Misovic B; Koppers-Lalic D; van Weering J; Beckers L; Adham M; Martorelli D; Middeldorp JM; Pegtel DM
    Int J Cancer; 2019 May; 144(10):2555-2566. PubMed ID: 30411781
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma vesicle miRNAs for therapy response monitoring in Hodgkin lymphoma patients.
    van Eijndhoven MA; Zijlstra JM; Groenewegen NJ; Drees EE; van Niele S; Baglio SR; Koppers-Lalic D; van der Voorn H; Libregts SF; Wauben MH; de Menezes RX; van Weering JR; Nieuwland R; Visser L; van den Berg A; de Jong D; Pegtel DM
    JCI Insight; 2016 Nov; 1(19):e89631. PubMed ID: 27882350
    [No Abstract]   [Full Text] [Related]  

  • 30. Comparison of Circulating miRNAs Expression Alterations in Matched Tissue and Plasma Samples During Colorectal Cancer Progression.
    Nagy ZB; Barták BK; Kalmár A; Galamb O; Wichmann B; Dank M; Igaz P; Tulassay Z; Molnár B
    Pathol Oncol Res; 2019 Jan; 25(1):97-105. PubMed ID: 28980150
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma miR-6089 as potential diagnostic biomarker for retinoblastoma.
    Li XH; Shi AJ; Li J; Yuan HF
    Int Ophthalmol; 2021 Jul; 41(7):2505-2512. PubMed ID: 33772700
    [TBL] [Abstract][Full Text] [Related]  

  • 32. miRNA Profiles in Extracellular Vesicles From Serum Early in Pregnancies Complicated by Gestational Diabetes Mellitus.
    Gillet V; Ouellet A; Stepanov Y; Rodosthenous RS; Croft EK; Brennan K; Abdelouahab N; Baccarelli A; Takser L
    J Clin Endocrinol Metab; 2019 Nov; 104(11):5157-5169. PubMed ID: 31058973
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of a plasma four-microRNA panel as potential noninvasive biomarker for osteosarcoma.
    Lian F; Cui Y; Zhou C; Gao K; Wu L
    PLoS One; 2015; 10(3):e0121499. PubMed ID: 25775010
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long Noncoding RNA LINC00202 Promotes Tumor Progression by Sponging miR-3619-5p in Retinoblastoma.
    Yan G; Su Y; Ma Z; Yu L; Chen N
    Cell Struct Funct; 2019; 44(1):51-60. PubMed ID: 30905893
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolic Syndrome Is Associated With Altered mRNA and miRNA Content in Human Circulating Extracellular Vesicles.
    Li Y; Meng Y; Zhu X; Van Wijnen A; Eirin A; Lerman LO
    Front Endocrinol (Lausanne); 2021; 12():687586. PubMed ID: 34456862
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
    Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G
    Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TGFBR2‑dependent alterations of microRNA profiles in extracellular vesicles and parental colorectal cancer cells.
    Fricke F; Mussack V; Buschmann D; Hausser I; Pfaffl MW; Kopitz J; Gebert J
    Int J Oncol; 2019 Oct; 55(4):925-937. PubMed ID: 31432155
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential profiles of microRNAs in retinoblastoma cell lines of different proliferation and adherence patterns.
    Jo DH; Kim JH; Park WY; Kim KW; Yu YS; Kim JH
    J Pediatr Hematol Oncol; 2011 Oct; 33(7):529-33. PubMed ID: 21941147
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sources to variability in circulating human miRNA signatures.
    Keller A; Rounge T; Backes C; Ludwig N; Gislefoss R; Leidinger P; Langseth H; Meese E
    RNA Biol; 2017 Dec; 14(12):1791-1798. PubMed ID: 28820329
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A circulating miRNA signature as a diagnostic biomarker for non-invasive early detection of breast cancer.
    Zhang L; Xu Y; Jin X; Wang Z; Wu Y; Zhao D; Chen G; Li D; Wang X; Cao H; Xie Y; Liang Z
    Breast Cancer Res Treat; 2015 Nov; 154(2):423-34. PubMed ID: 26476723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.